Companies · Other Health Care
ISFIYA · Other Health Care
Diligence memoA one-page analyst read on Check-Cap Ltd — recommendation, valuation, rhythm, risks.→Check-Cap Ltd looks over-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Check-Cap Ltd is one of 5377 Other Health Care companies tracked from ISFIYA. By capital raised it ranks in the upper tier (ahead of 87% of sector peers), and in the upper tier by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.
Round size and date are reported; the stage label is inferred from round size (latest is Series A — a $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 87% of sector peers (real $). Modeled value above 87% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #20 of 164.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| InvestCo Tabletop, LLC | Series A | $15.0M | $302.7M | 3.00× |
| Mediphore, Inc. | Series A | $15.0M | $302.7M | 3.00× |
| iVinci Partners, LLC | Series A | $34.8M | $302.7M | 3.00× |
| Oklahoma Proton Center LLC | Series A | $14.0M | $282.5M | 2.80× |
| MicroOptx, Inc. | Series A | $17.8M | $278.6M | 2.76× |
| ProxsysRx, Inc. | Series A | $14.6M | $260.0M | 2.58× |
| Biolux Research Holdings, Inc. | Series A | $12.7M | $256.3M | 2.54× |
| Fountain Life Holdings, LLC | Series A | $17.1M | $238.6M | 2.36× |
| Equality Management Holdings, LLC | Series A | $14.4M | $232.3M | 2.30× |
| Olympus Ascent Investors, LLC | Series A | $11.5M | $232.0M | 2.30× |
| EDS Holdco LLC | Series A | $12.3M | $221.5M | 2.20× |
| Zipari, Inc. | Series A | $29.6M | $208.3M | 2.06× |
| Check-Cap Ltd this company | Series A | $26.0M | $190.3M | 1.89× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Seed | $2.7M | 2017-05-29 | $13.5M | $66.9M | 90% |
| Seed | $2.1M | 2017-11-20 | $10.7M | $52.8M | 90% |
| Series A | $4.0M | 2020-04-20 | $18.2M | $80.7M | 90% |
| Series A | $4.5M | 2020-04-30 | $20.5M | $90.8M | 90% |
| Series A | $3.0M | 2020-05-08 | $13.6M | $60.5M | 90% |
| Series A | $9.6M | 2020-07-23 | $43.8M | $190.3M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Walter Robb | — | 10 other | 2017-05 |
| Mary Jo Gorman | — | 3 other | 2017-05 |
| Tomer Kariv | — | 2 other | 2017-05 |
| Steven Hanley | — | 1 other | 2017-05 |
| William Densel. | — | 1 other | 2017-05 |
| Alex Ovadia | — | — | 2017-05 |
| Boaz Shpigelman | — | — | 2020-04 |
| Clara Ezed | — | — | 2017-11 |
| Israel Hershko | — | — | 2020-04 |
| Joshua Belkar | — | — | 2020-04 |
| Lior Torem | — | — | 2017-05 |
| Mira Rosenzweig | — | — | 2020-04 |
| Vardit Segal | — | — | 2020-04 |
| XiangQian Lin | — | — | 2017-05 |
| XiangQian (XQ) Lin | — | — | 2020-04 |
| Yoav Kimchy | — | — | 2017-05 |
| Yuval Yanai | — | — | 2017-05 |
Check-Cap Ltd is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Advanced Icu Care, Inc. | Other Health Care | Series A | $17.8M | $147.8M | network1 shared operator · same sector · same stage |
| AbsoluteCARE, Inc. | Other Health Care | Series A | $25.7M | $242.6M | same sector · same stage |
| OptimizeRx Corp | Other Health Care | Series A | $25.5M | $181.6M | same sector · same stage |
| SwipeSense, Inc. | Other Health Care | Series A | $27.0M | $214.2M | same sector · same stage |
| Dynatronics Corp | Other Health Care | Series A | $24.8M | $141.3M | same sector · same stage |
| C D Services of AMERICA, LLC | Other Health Care | Series A | $27.4M | $176.8M | same sector · same stage |
| CardioInsight Technologies, Inc. | Other Health Care | Series A | $24.3M | $151.3M | same sector · same stage |
| BehaveCare Inc. | Other Health Care | Series A | $24.3M | $137.1M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| MedChefs, Inc. | Other Health Care | Pre-Seed | $990K | 82% |
| Quotient Ltd | Other Health Care | Series C | $918.1M | 81% |
| Neatcap, LLC | Other Health Care | Pre-Seed | $3.0M | 81% |
| Eyecheq Inc. | Other Health Care | Seed | $18.7M | 81% |
| Porter Cares, Inc. | Other Health Care | Series B | $183.9M | 81% |
| Scientific Intake Ltd Co | Other Health Care | Seed | $11.3M | 81% |
| CareMax, Inc. | Other Health Care | Series B | $14.1M | 81% |
| Luminus Holdings Corp | Other Health Care | Series A | $100.9M | 81% |
See where Check-Cap Ltd sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Check-Cap Ltd, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.